Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Yanagisawa

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Chemical & Pharmaceutical Bulletin|March 21, 1998
Studies on nonpeptide angiotensin II receptor antagonists. II. Synthesis and biological evaluation of 5H-pyrazolo[1,5-b][1,2,4]triazole derivatives with a C-linked oxygen functional group at the 6-positionT Okazaki, A Suga, T Watanabe, et al.
Chemical & Pharmaceutical Bulletin|June 1, 2001
Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonistsH Harada, J Kazami, S Watanuki, et al.
European Journal of Pharmacology|November 22, 1997
Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogsM Shibasaki, A Fujimori, T Kusayama, et al.
European Journal of Pharmacology|November 22, 1997
Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonistM Shibasaki, A Fujimori, M Takanashi, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1994
Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aortaW Uchida, Y Hirano, Y Shirai, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1996
Novel potassium channel activators: synthesis and structure-activity relationship studies of 3,4-dihydro-2H-1,4-benzoxazine derivativesY Matsumoto, R Tsuzuki, A Matsuhisa, et al.
Chemical & Pharmaceutical Bulletin|January 5, 2002
Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonistsH Harada, J Kazami, S Watanuki, et al.
Biochimie|January 1, 1996
Biochemical characterization of a new disintegrin, flavostatin, isolated from Trimeresurus flavoviridis venomT Kawasaki, Y Sakai, Y Taniuchi, et al.
Thrombosis and Haemostasis|April 8, 1998
Enhancement of tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by combination with a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, in a rhesus monkey model of coronary thrombosisT Kawasaki, K Sato, K Suzuki, et al.
European Journal of Pharmacology|September 19, 1996
Synergistic effect of aurintricarboxylic acid and triflavin in a photochemically induced thrombosis model in ratsN Hisamichi, T Kawasaki, K Suzuki, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Chemical & Pharmaceutical Bulletin|March 21, 1998
Studies on nonpeptide angiotensin II receptor antagonists. II. Synthesis and biological evaluation of 5H-pyrazolo[1,5-b][1,2,4]triazole derivatives with a C-linked oxygen functional group at the 6-positionT Okazaki, A Suga, T Watanabe, et al.
Chemical & Pharmaceutical Bulletin|June 1, 2001
Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonistsH Harada, J Kazami, S Watanuki, et al.
European Journal of Pharmacology|November 22, 1997
Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogsM Shibasaki, A Fujimori, T Kusayama, et al.
European Journal of Pharmacology|November 22, 1997
Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonistM Shibasaki, A Fujimori, M Takanashi, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|May 1, 1994
Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aortaW Uchida, Y Hirano, Y Shirai, et al.
Chemical & Pharmaceutical Bulletin|January 1, 1996
Novel potassium channel activators: synthesis and structure-activity relationship studies of 3,4-dihydro-2H-1,4-benzoxazine derivativesY Matsumoto, R Tsuzuki, A Matsuhisa, et al.
Chemical & Pharmaceutical Bulletin|January 5, 2002
Synthesis and structure-activity relationships in a series of ethenesulfonamide derivatives, a novel class of endothelin receptor antagonistsH Harada, J Kazami, S Watanuki, et al.
Biochimie|January 1, 1996
Biochemical characterization of a new disintegrin, flavostatin, isolated from Trimeresurus flavoviridis venomT Kawasaki, Y Sakai, Y Taniuchi, et al.
Thrombosis and Haemostasis|April 8, 1998
Enhancement of tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by combination with a humanized anti-glycoprotein IIb/IIIa monoclonal antibody, YM337, in a rhesus monkey model of coronary thrombosisT Kawasaki, K Sato, K Suzuki, et al.
European Journal of Pharmacology|September 19, 1996
Synergistic effect of aurintricarboxylic acid and triflavin in a photochemically induced thrombosis model in ratsN Hisamichi, T Kawasaki, K Suzuki, et al.
Pageof 5